Freenome

About Freenome

Freenome is a high-growth biotech company on a mission since 2014 to create tools that empower everyone to prevent, detect, and treat their disease.

To achieve this mission, Freenome is developing next-generation blood tests to detect cancer in its earliest, most treatable stages using our multiomics platform and machine learning techniques. Our first blood test will detect early-stage colorectal cancer and advanced adenomas.

We have raised more than $1.1 billion from leading investors like Perceptive Advisors, RA Capital Management, Roche Venture Fund, Kaiser Permanente, Novartis and the American Cancer Society’s BrightEdge Ventures.

A ‘Freenomer’ is a mission-driven employee who is fueled by the opportunity to make a positive impact on patients' lives, who thrives in a culture of respect and cross collaboration, and whose work makes a significant impact on the company and their career.

Website	http://www.freenome.com
Employees	201-500 employees View all Freenome employees
Industry	Biotechnology
Phone number	650-446-6630
Headquarter	279 E Grand Ave, South San Francisco, California 94080, US
Founded	2014
Keywords	Biotechnology, Oncology, Machine Learning, Molecular Diagnostics, Oncology, Early Cancer Detection, Computational Biology, Early Cancer Detection, Cancer Screening, Cancer Screening, Multiomics, Multiomics, Molecular Diagnostics, Biotechnology, Machine Learning